Pharma patent licensing surge falters IAM
Despite expectations of a bumper year, pharma patent licensing activity in 2018 fell to its lowest level since 2013, according to new figures released by …
Pharma patent licensing surge falters IAM
Despite expectations of a bumper year, pharma patent licensing activity in 2018 fell to its lowest level since 2013, according to new figures released by …